Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.805 USD | +1.26% | +4.40% | +112.69% |
May. 07 | Transcript : Trevi Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+112.69% | 195M | |
+9.96% | 115B | |
+11.86% | 106B | |
-2.59% | 21.96B | |
-12.82% | 21.87B | |
-5.29% | 19.21B | |
-3.84% | 18.08B | |
-38.57% | 17.71B | |
+7.28% | 14.32B | |
+35.10% | 12.42B |
- Stock Market
- Equities
- TRVI Stock
- News Trevi Therapeutics, Inc.
- Needham Trims Price Target on Trevi Therapeutics to $8 From $10, Maintains Buy Rating